Yuanyuan Wu

Yuanyuan Wu

Auto-generated profile, based on publicly available information

Yuanyuan Wu

Nantong University

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Open access
PDF file
YWYuanyuan Wu
Yuanyuan Wu
WCWeiwei Chen
Weiwei Chen
YZYufang Zhang
Yufang Zhang
ALAifen Liu
Aifen Liu
CYCheng Yang
Cheng Yang
BYBin Yang
Bin Yang
Target-specific treatment is not available for acute kidney injury (AKI). A novel erythropoietin-derived cyclic helix B surface peptide (CHBP) protects kidneys against AKI subjected to different causes. Herein, we investigated the transcriptional profile of renoprotection induced by CHBP and its potential synergistic effects with caspase-3 (an executing enzyme of apoptosis and inflammation) siRNA (CASP3siRNA) on ischemia/reperfusion (IR)-induced AKI. Utilizing a mouse model with renal bilateral 30-min ischemia and 48-h reperfusion, the renoprotective effects of a single dose of CHBP (24 nmol/kg) or CASP3siRNA (0.03 mg/kg) were demonstrated on renal function and structure, active 17 kDa caspase-3 and HMGB1 expression in IR kidneys. Combined treatment of CHBP and CASP3siRNA further preserved kidney structure, and reduced active caspase-3 and HMGB1. Furthermore, fold change > 1.414 and P < 0.05 were used to identify differentially expressed genes (DEGs). In IR kidneys, 281 DEGs induced by CHBP were mainly involved in promoting cell division and improving cellular function and metabolism (up-regulated STAT5B and SLC22A7). The additional administration of CASP3siRNA caused 504 and 418 DEGs in IR + CHBP kidneys with or without NCsiRNA, with 37 genes in common. These DEGs were associated with modulated apoptosis and inflammation (up-regulated BCL6,SLPI and SERPINA3M), and immunity, injury and microvascular homeostasis (up-regulated CFH and GREM1, and down-regulated ANGPTL2). This proof-of-effect study indicated that the synergistic renoprotection of CHBP and CASP3siRNA at the early stage of IR-induced AKI. Underlying genes, BCL6, SLPI, SERPINA3M, GREM1 and ANGPTL2, might be potential new biomarkers for clinical applications. Significance Statement The synergistic renoprotection of erythropoietin derived peptide CHBP and siRNA targeting CASP3 was achieved by better preserved kidney structure and reduced injury mediator at the early stage of IR-induced AKI. The mechanistic study of gene profiling revealed more candidate genes such as BCL6, SLPI and SERPINA3M, associated with cell function, metabolism and immune response, might be potential new biomarkers of diagnosis and siRNA therapy for IR-induced AKI.

27 October 2013 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
YWYuanyuan Wu
Yuanyuan Wu
JZJunlin Zhang
Junlin Zhang
FLFeng Liu
Feng Liu
CYCheng Yang
Cheng Yang
YZYufang Zhang
Yufang Zhang
BYBin Yang
Bin Yang
Ischemia reperfusion (IR) and cyclosporine A (CsA) injuries are unavoidable in kidney transplantation and are associated with allograft dysfunction. Herein, the effect and mechanism of a novel tissue protective peptide, helix B surface peptide (HBSP) derived from erythropoietin, were investigated in a rat model. The right kidney was subjected to 45 min ischemia, followed by left nephrectomy and 2-week reperfusion, with or without daily treatment of CsA 25 mg/kg and/or HBSP 8 nmol/kg. Blood urea nitrogen was increased by CsA but decreased by HBSP at 1 week and 2 weeks, while the same changes were revealed in urinary protein/creatinine only at 2 weeks. HBSP also significantly ameliorated tubulointerstitial damage and interstitial fibrosis, which were gradually increased by IR and CsA. In addition, apoptotic cells, infiltrated inflammatory cells, and active caspase-3+ cells were greatly reduced by HBSP in the both IR and IR + CsA groups. The 17 kD active caspase-3 protein was decreased by HBSP in the IR and IR + CsA kidneys, with decreased mRNA only in the IR + CsA kidneys. Taken together, it has been demonstrated, for the first time, that HBSP effectively improved renal function and tissue damage caused by IR and/or CsA, which might be through reducing caspase-3 activation and synthesis, apoptosis, and inflammation.

9 June 2022 in Energy Reports
Verified
Journal Article
Open access
JCJunhao Cui
Junhao Cui
GTGuizhen Tian
Guizhen Tian
GLGuangchen Liu
Guangchen Liu
YWYuanyuan Wu
Yuanyuan Wu
ZGZi-Hao Guo
Zi-Hao Guo

25 November 2024 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
LHLili Huang
Lili Huang
YWYuanyuan Wu
Yuanyuan Wu
WSWenli Sai
Wenli Sai
YWYanan Wang
Yanan Wang
GFGuijuan Feng
Guijuan Feng
BYBin Yang
Bin Yang
Sepsis‐associated acute kidney injury (AKI) has high morbidity and mortality, but without cause‐specific treatment. Erythropoietin derived Helix B surface peptide (HBSP) alleviates AKI, whereas its underlying mechanisms remain to be further explored. Here, the effects of HBSP on pyroptosis, apoptosis, macrophage polarization and repair were investigated in lipopolysaccharide (LPS)‐induced AKI mouse model and cultured kidney epithelial cells. Systemic inflammation, compromised renal function and histology were demonstrated in LPS‐treated mice, with upregulated pyroptotic and apoptotic key proteins in the kidneys including GSDMD‐N, cleaved IL‐1β, IL‐18 and caspase‐3. These proteins were localized in tubular areas and colocalized with aquaporin‐1 (AQP1), with increased F4/80+ M1 macrophages. However, HBSP mitigated pyroptosis, apoptosis and inflammation, and promoted macrophage M2 polarization. In addition, HMGB1 and erythropoietin receptor (EPOR) were increased by LPS and decreased by HBSP, both of which were positively correlated with pyroptotic and apoptotic proteins. Moreover, HBSP reduced TNF‐α and IL‐6 mRNA levels, as well as pyroptosis and apoptosis in LPS‐stimulated TCMK‐1 cells. In conclusion, HBSP inhibited tubular pyroptosis and apoptosis, EPOR expression, promoted macrophage M2 polarization, and protected against LPS‐induced AKI. These findings provide new mechanistic insights into the renoprotection of HBSP, and facilitate its potential for clinical applications and therapeutic strategies in sepsis‐associated AKI.

9 October 2017 in Current Protein & Peptide Science
Verified
Journal Article
Closed access
PDF file
YZYufang Zhang
Yufang Zhang
WCWeiwei Chen
Weiwei Chen
YWYuanyuan Wu
Yuanyuan Wu
BYBin Yang
Bin Yang
The renoprotection of erythropoietin (EPO) and its derivatives such as helix B surface peptide (HBSP) have attracted a great deal of attention from scientists and clinicians alike. The evolutional achievement in the dissociation of tissue protection and erythropoiesis is obtained through HBSP characterisation and synthesis. We performed a series of studies using EPO, as well as HBSP, in a variety of biological models subjected to transplant-related renal injuries such as ischemia reperfusion injury (IRI) and/or immunosuppressant nephrotoxicity. In this short review, we would like to address the effects of EPO in different formats, and its underlying mechanisms with focuses on apoptosis and inflammation in in vitro, ex vivo and in vivo renal injury models, and to further explore potential applications and challenges in humans.

15 October 2013 in Journal of Molecular Histology
Verified
Journal Article
Closed access
PDF file
JZJiaming Zhou
Jiaming Zhou
LCLi Chen
Li Chen
YZYixin Zhang
Yixin Zhang
YWYuanyuan Wu
Yuanyuan Wu
GWGuilan Wang
Guilan Wang
YWYingze Wei
Yingze Wei